BIT 2.22% 4.6¢ biotron limited

$10 Billion Deal, page-8173

  1. 5,587 Posts.
    lightbulb Created with Sketch. 657
    How much will Phase 2b and 3 cost? Is it still progressing since the aweful BIT225 assay results 'screened, not a selected hit' ?

    It will cost waaaay more than what they currently have on hand

    They also need more 'do-ers', lease premises, and equipment to do anything material to strengthen the Balance Sheet...so cash burn will continue to increase and weaken the Balance Sheet as Cash is the only major asset unfortunately

    Poor form management, poor form

    Where will they get cash from? I reckon, firstly from a Equity Raise at a price which is much much lower diluting existing shareholders and pushing any commercial deal down the road AGAIN

    Here's what I perceive as the commercially weakening BIT225 results below. OOPSIE! and why can't management disclose these?...perhaps they want out at a higher price before public discovery...without transparency its not 100% known but with these guys and how they operate..its a high probability that this has been happening since 10c+ days...

    38 assays and not a single hit from what they say is their best compound let that sink into your heads

    https://hotcopper.com.au/data/attachments/3109/3109544-bb37750d2c465a573bf479592a1aa8ff.jpg


    ASSAY TYPE INDICATIONSCREENING HITASSAY SOURCE
    1TSRI: CoV-2/HeLa-ACE2
    SARS-COV2
    screened, not a selected hitCalibr
    2TB oxidative phosphorylation inhibitor
    M. TUBERCULOSIS
    screened, not a selected hitCalibr
    3TB IMAC Assay
    TUBERCULOSIS
    screened, not a selected hitCalibr
    4Crypto-C. parvum proliferation (Sterling)
    CRYPTOSPORIDIOSIS
    screened, not a selected hitCalibr
    5TB growth inhibition
    M. TUBERCULOSIS
    screened, not a selected hitCalibr
    6Intracellular nonreplicating MTB screen
    TUBERCULOSIS
    screened, not a selected hitCalibr
    7STING agonist
    IMMUNOONCOLOGY; ADJUVANTS
    screened, not a selected hitCalibr
    8Wolbachia high-content imaging
    HELMINTH: ANTI-WOLBACHIA
    screened, not a selected hitCalibr
    9Malaria Sporontocidals
    MALARIA
    screened, not a selected hitCalibr
    10Zika cytopathic effect inhibition (SH-SY5Y)
    ZIKA
    screened, not a selected hitCalibr
    11Zika Cytopathic Effect Inhibition in Vero E6 cells
    ZIKA
    screened, not a selected hitCalibr
    12TB Tyr-tRNA synthetase inhibitor
    M. TUBERCULOSIS
    screened, not a selected hitCalibr
    13A. baumannii HUMC1 Viability serum
    EXTENSIVELY DRUG-RESISTANT ACINETOBACTER BAUMANNII
    screened, not a selected hitCalibr
    14Intramacrophage Mycobacterium tuberculosis
    TUBERCULOSIS
    screened, not a selected hitCalibr
    15TB DGr
    TUBERCULOSIS
    screened, not a selected hitCalibr
    16MAVS Aggregation Assay
    IMMUNOONCOLOGY; ADJUVANTS
    screened, not a selected hitCalibr
    17A. baumannii HUMC1 Meropenem Potentiation serum
    EXTENSIVELY DRUG-RESISTANT ACINETOBACTER BAUMANNII
    screened, not a selected hitCalibr
    18Burkholderia pseudomallei K96243
    MELIOIDOSIS
    screened, not a selected hitCalibr
    19Screen in Luciferase-expressing E. histolytica
    AMEBIASIS
    screened, not a selected hitCalibr
    20Viability on Pathogenic Acanthamoeba Castellanii
    GRANULOMATOUS AMEBIC ENCEPHALITIS (GAE)
    screened, not a selected hitCalibr
    21Cell Viability on Pathogenic Naegleria fowleri
    PRIMARY AMOEBIC MENINGOENCEPHALITIS (PAM)
    screened, not a selected hitCalibr
    22Shigella flexneri growth inhibition
    SHIGELLOSIS
    screened, not a selected hitCalibr
    23SigmaE-Hfq inhibition
    BACTERIAL INFECTIONS
    screened, not a selected hitCalibr
    24Giardia 1536w Luciferase Assay
    GIARDIASIS
    screened, not a selected hitCalibr
    25LCMV Inhibitors
    MAMMARENAVIRUS LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV)
    screened, not a selected hitCalibr
    26tmRNA
    BACTERIAL INFECTIONS
    screened, not a selected hitCalibr
    27Trypanosoma cruzi Assay
    CHAGAS
    screened, not a selected hitCalibr
    28THP1-ISRE-SEAP
    IMMUNOONCOLOGY; ADJUVANTS
    screened, not a selected hitCalibr
    29Male Contraceptive Screen (Motility)
    HUMAN CONTRACEPTION
    screened, not a selected hitCalibr
    30Inhibitor of microbial choline metabolism
    GROWTH OF E. COLI ON CHOLINE-CONTAINING MINIMAL MEDIA
    screened, not a selected hitCalibr
    31WRAIR LADR-luc Assay (4 day)
    CUTANEOUS LEISHMANIASIS
    screened, not a selected hitCalibr
    32Biofilm-Inhibitory of Candida Growth
    CANDIDIASIS
    screened, not a selected hitCalibr
    33ppGpp hydrolysis assay
    TUBERCULOSIS
    screened, not a selected hitCalibr
    34Block Rings and Gametocytes to Eradicate Malaria
    PLASMODIUM FALCIPARUM
    screened, not a selected hitCalibr
    35Mtb TrpRS Biochemical Screening
    TUBERCULOSIS
    screened, not a selected hitCalibr
    36Screen against Klebsiella pneumoniae (Kp) 757
    KLEBSIELLA PNEUMONIAE INFECTIONS
    screened, not a selected hitCalibr
    37hRSV High Throughput Screen
    HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV)
    screened, not a selected hitCalibr
    38DENV transmission blocking molecules (U4.4 cells)
    DENGUE VIRUS INFECTION (DENGUE FEVER AND HEMORRHAGIC FEVER)
    screened, not a selected hitCalibr


 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.